Analysts on Wall Street project that Encompass Health (EHC) will announce quarterly earnings of $0.94 per share in its forthcoming report, representing an increase of 9.3% year over year. Revenues are projected to reach $1.33 billion, increasing 10% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's ear ...

BIRMINGHAM, Ala., Oct. 22, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be November 21, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Co ...

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Encompass Health (EHC) and Astrana Health, Inc. (ASTH) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate re ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Encompass Health (EHC) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on October 28, 2024, might help the stock move higher if these key numbers are better ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Encompass Health (EHC) . This company, which is in the Zacks Medical - Outpatient and Home Healthcare industry, shows potential for another earnings beat. When looking at the last two reports, this rehabilitation hospital operator has recorded a strong streak of surpassing earnings estimates. The company has topped estimates b ...

Encompass Health (EHC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Individual investo ...

Encompass Health Corporation (EHC) has been gaining on growing patient admissions, commendable expansion initiatives and a robust cash position. A solid 2024 business outlook also reinforces investors' confidence in the stock. EHC's Zacks Rank & Price Performance Encompass Health currently carries a Zacks Rank #3 (Hold). The stock has gained 43.4% in the past year compared with the industry's 34.5% growth. The Zacks Medical sector has rallied 13.1% and the S&P 500 composite increased 33.4% in the same time ...

Encompass Health Rehabilitation Hospital of Fort Mill provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients receive a minimum of three hours of intensive therapy for five days each week, frequent physician visits and 24-hour nursing care. "The need for inpatient rehabilitative care in the Fort Mill and greater Charlotte area has been growing rapidly" ...

Encompass Health Corporation (EHC) shares have shot up 39.4% in the year-to-date period, outperforming the industry's return of 17.9% and the S&P 500 Index's rise of 18.4%. Growing patient volumes and impressive growth-related initiatives appear to have catalyzed this bullishness. Currently priced at $93.05, the stock is just 1.4% below its 52-week high of $94.38. This proximity underscores investor confidence and market optimism about this healthcare company's prospects. It has the ingredients for further ...

Investors might want to bet on Encompass Health (EHC) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. In ...